Ingredion Incorporated (INGR) Income Statement

The persistent negative revenue growth, from -11.9% in 2024Q1 to -0.9% in 2026Q2, suggests a prolonged demand softness or pricing pressure, likely reflecting lower corn prices and volume challenges in core segments. The deceleration appears to be moderating, but the lack of positive growth indicates that the company has not yet returned to expansion, and investors should monitor whether the specialty portfolio can offset core declines.

The stability in gross margin, despite revenue contraction, suggests that the company's pricing power and cost pass-through mechanisms are functioning, but the margin is structurally constrained by the commodity nature of core ingredients. The slight dip in 2026Q2 to 23.0% from 24.5% in 2025Q4 may indicate input cost pressure or a temporary mix shift, but the overall range suggests a resilient business model. The shift toward specialty ingredients, which carry higher margins, appears to be offsetting some of the commodity headwinds, but the pace of mix improvement is slow.

The sharp decline in operating margin, despite relatively stable gross margins, indicates that operating expenses are not scaling down with revenue, or that fixed costs are becoming a larger burden as volumes decline. This suggests that the company's cost structure is not flexible enough to fully offset revenue declines, and the recent sequential improvement from 10.2% to 11.2% in 2026Q1 may be a positive sign, but the overall trend is concerning. Investors should monitor whether management can achieve further cost reductions to restore operating leverage.

The high proportion of COGS underscores the commodity-driven nature of the business, where raw material costs are the primary expense. The stability in gross margin suggests that the company is effectively passing through corn costs, but the lack of R&D and SG&A data in the provided figures limits deeper analysis of overhead efficiency. The recent operating margin compression indicates that SG&A or other operating expenses may be rising relative to revenue, warranting further investigation into cost discipline.

The sharp margin contraction in 2024Q4 appears to be a significant inflection, likely driven by impairment charges, restructuring costs, or a sudden drop in demand, as revenue also declined 6.3% year-over-year. This quarter stands out as a trough, with subsequent quarters showing recovery to around 14-15% margins in 2025, but the 2026Q2 margin of 10.2% suggests a new downward trend. The lasting impact may be a more cautious approach to cost management, but the volatility highlights the cyclicality of the business and the need for investors to focus on normalized margins.